Experimental Pill Nearly Doubles Survival in Pancreatic Cancer
A late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
Compare ongoing fees across top dividend ETFs for 2024 to find the funds with the lowest drag on your returns and best value.
28,084 articlesA late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
A dramatic earnings miss sent EHang stocks lower, highlighting the challenges facing early-stage eVTOL developers. Th...
Big banks are expanding crypto custody by investing in vaulting for Bitcoin and Ethereum. Yet a Taurus report warns q...
A recent insider move at Lindblad Expeditions Holdings drew attention from investors. This article breaks down what h...
The Commerce Department reported May PCE inflation rose 0.4% month-on-month, pushing the annual pace to 4.1%. Core PC...
AMD and Marvell released quarterly results centered on AI infrastructure, highlighting different strategic bets in da...
An investor-oriented deep dive into Lyft's leadership under David Risher and how the MiB framework guides growth, eff...
June’s producer price index fell 0.3% from May as energy prices slid, signaling cooling inflation. Yet geopolitical t...
AI's energy appetite is growing. This article explains how these energy stocks helping power AI’s rise and what it me...
Micron Technology and SanDisk shares tumbled in early trading as energy-price volatility tests cost structures at glo...
Nvidia's CEO argues the AI data-center expansion is only beginning, with trillions more in infrastructure needed. Mar...
Many savers depend on one retirement account, assuming it will carry them through. This article shows why that mindse...